Clinical Trials: Emerald Clinical Trials is a leading clinical research organization operating worldwide that serves over 100 biotechs, and 6 of the top 10 pharmaceutical companies. Headquartered in Singapore and driven by operational expertise and...
Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-dose vial). Glenmark's Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25...
Initiative (ADNI), Spectris patients maintained brain volume (+0.58%) while matched ADNI controls showed a decline (-0.91%), a net difference of +1.49% (p
chemically synthesized and animal component-free, enabling xeno-free and chemically defined cell culture media. PG-012, KGF alternative peptide, is a dimeric peptide composed of cyclic peptides designed to bind specifically to FGFR2b. Like KGF,...
active ingredients into a single capsule. Laboratorios Silanes, a leading pharmaceutical company in Mexico founded in 1943, is committed to providing innovative healthcare solutions and driving rapid growth in the industry. It has established...
support models that grow with your business—ensuring the right expertise, at the right time. About Truliant: Founded in 2021 and headquartered in Baltimore, Maryland, Truliant Consulting is a women-owned business specializing in pharmacovigilance...
and management to health systems in the U.S. and U.K., announced it has been named by Fast Company as one of the World's 10 Most Innovative Companies in the medical device category. Profiled in the publication's March 18 feature, Bruin Biometrics...
Headquartered in Northfield, Illinois, the company employs more than 43,000 people worldwide and operates in more than 100 countries and territories. For more information please visit www.medline.com.
can progress to secondary myelofibrosis or leukemia. The global incidence of PV is estimated at approximately 2.8 cases per 100,000 people per year. In Brazil, between 2016 and 2020, DataSUS recorded 1,843 cases of Polycythemia Vera, representing...
medicine, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to STM-01, the company’s neonatal cardiac progenitor cell (nCPC) therapy, for the treatment of Heart Failure with Preserved Ejection Fraction...
President: Kyoko Deguchi), and Cyfuse Biomedical K.K. announce the successful development of a new production technology(*1) for the commercialization of the field of regenerative and cell therapy. This achievement is the result of a strategic...
Company’s common stock will begin trading under the new Nasdaq symbol “NAGE” at stock market open today, Wednesday, March 19, 2025. The CUSIP number for the Company's common stock will remain the same. With a legacy spanning over 25 years, this...
on prosthetic types (e.g., Provisional Bridge, Denture) for an expanded workflow. Medit revolutionized the market in 2018 with its first intraoral scanner, offering high precision and user-friendly options at a significantly lower cost than...
treating relapsed refractory AML patients with CLAG-M. Actimab-A + CLAG-M Trial Data Highlights from Publication: 18.4 month median Overall Survival (OS) in patients who received 1 or 2 lines of prior therapy 52% of patients in the Actimab-A...
by the couple's respective careers in biomedical science and art history. Since 2000, the foundation has awarded over $15 million in prizes and grants. The Vilcek Foundation is a private operating foundation, a federally tax-exempt nonprofit...
labelled, PSMA targeted, investigational radioligand therapy. Radiation dosimetry and pharmacokinetic data from the 13 metastatic castrate resistant prostate cancer patients enrolled in the Phase 1 portion of a Phase 1/2 clinical trial...
Inc. announces the execution of a clinical trial agreement with the National Institutes of Health (NIH) to sponsor a Phase 1 clinical trial of FZ002 for C. difficile treatment. Oral FZ002 is a live yeast genetically modified to express a...
Currax Pharmaceuticals LLC a specialty pharmaceutical company and manufacturer of the #1 branded oral weight loss medication CONTRAVE® (naltrexone HCl/bupropion HCl), announced the publication of its Cardiovascular Health Outcomes Analysis (HOA)...
CordenPharma provides development and manufacturing services for clinical and commercial demand of Viking Therapeutics' GLP-1 drug candidate VK2735, a Dual GLP-1/GIP Receptor Agonist, across the full supply chain from drug substance to drug product...
potential to transform the lives of individuals with immunodeficiency. About Kenox Pharmaceuticals Inc.: Established in 2018 and based in the greater Princeton area, NJ, Kenox specializes in pharmaceutical aerosol product development, including...